Peppers and pain - The promise of capsaicin

被引:62
|
作者
Fusco, BM
Giacovazzo, M
机构
[1] Department of Clinical Medicine, University La Sapienza, Rome
[2] Department of Clinical Medicine, University La Sapienza, Policlinico Umberto I, 00161 Rome, Viale del Policlinico
关键词
D O I
10.2165/00003495-199753060-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Capsaicin, the most pungent ingredient in red peppers, has been used for centuries to remedy pain. Recently, its role has come under reinvestigation due to evidence that the drug acts selectively on a subpopulation of primary sensory neurons with a nociceptive function. These neurons, besides generating pain sensations, participate through an antidromic activation in the process known as neurogenic inflammation. The first exposure to capsaicin intensely activates these neurons in both senses (orthodromic:pain sensation; antidromic: local reddening, oedema etc.). After the first exposure, the neurons become insensitive to all further stimulation (including capsaicin itself). This evidence led to the proposal of capsaicin as a prototype of an agent producing selective analgesia. This perspective is radically different from previous 'folk medicine' cures, where the drug was used as a counter-irritating agent (i.e. for muscular pain). The new concept requires that capsaicin be repeatedly applied on the painful area to obtain the desensitisation of the sensory neurons. Following this idea, capsaicin has been used successfully in controlling pain in postherpetic neuralgia, diabetic neuropathy and other conditions of neuropathic pain. Furthermore, evidence indicates that capsaicin could also control the pain of osteoarthritis. Finally, repeated applications of the drug to the nasal mucosa result in the prevention of cluster headache attacks. On the basis of this evidence, capsaicin appears to be a promising prototype for obtaining selective analgesia in localised pain syndromes.
引用
收藏
页码:909 / 914
页数:6
相关论文
共 50 条
  • [21] Reactivation of mutant p53 by capsaicin, the major constituent of peppers
    Alessia Garufi
    Giuseppa Pistritto
    Mara Cirone
    Gabriella D’Orazi
    Journal of Experimental & Clinical Cancer Research, 35
  • [22] Reactivation of mutant p53 by capsaicin, the major constituent of peppers
    Garufi, Alessia
    Pistritto, Giuseppa
    Cirone, Mara
    D'Orazi, Gabriella
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [23] OPTIMIZATION AND VALIDATION OF A LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF CAPSAICIN IN CHILI PEPPERS
    Pavon-Perez, Jessy
    Pena-Farfal, Carlos
    Aranda, Mario
    Henriquez-Aedo, Karem
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2019, 64 (02): : 4475 - 4479
  • [24] Chilli peppers hold the key to pain
    不详
    CHEMISTRY & INDUSTRY, 1997, (21) : 851 - 851
  • [25] Ultrasound-Assisted Extraction of Capsaicin from Red Peppers and Mathematical Modeling
    Yue, Long
    Zhang, Feng
    Wang, Zhixiang
    SEPARATION SCIENCE AND TECHNOLOGY, 2012, 47 (01) : 124 - 130
  • [26] Dose Response Function for Capsaicin in the Context of Reported Liking and Intake of Chili Peppers
    Nolden, Alissa A.
    Hayes, John E.
    CHEMICAL SENSES, 2016, 41 (07) : E107 - E108
  • [27] Capsaicin-the spicy ingredient of chili peppers: A review of the gastrointestinal effects and mechanisms
    Xiang, Qunran
    Guo, Weiling
    Tang, Xin
    Cui, Shumao
    Zhang, Feng
    Liu, Xiaoming
    Zhao, Jianxin
    Zhang, Hao
    Mao, Bingyong
    Chen, Wei
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2021, 116 : 755 - 765
  • [28] Capsaicin in hot chili peppers as a potent free radical scavenger: An in vitro approach
    Kalaiyarasi, D.
    Manobharathi, V
    Mirunalini, S.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (04): : 68 - 75
  • [29] Tumor Cell Growth Inhibition Is Correlated With Levels of Capsaicin Present in Hot Peppers
    Dou, Dan
    Ahmad, Aamir
    Yang, Huanjie
    Sarkar, Fazlul H.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (02): : 272 - 281
  • [30] Capsaicin receptor in the pain pathway
    Tominaga, M
    Julius, D
    JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 83 (01): : 20 - 24